CHEK2 C1100del mutation associated with papillary renal cell carcinoma type II

CHEK2 mutations have been noted in bone, brain, breast, colon, lung, thyroid, and prostate cancer. Although now reported in both clear cell and non-clear cell renal cancer, we have not found CHEK2 2 mutations reported in the papillary type II subtype (PRCC). Here, we report a 63-year-old female with...

Full description

Bibliographic Details
Main Authors: Santiago J. Lopez, H. James Williams, Thomas Francis Hogan
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Urology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214442023001079